Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 738625, 10 pages
http://dx.doi.org/10.1155/2014/738625
Research Article

IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes

Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Yoshida-gun, Fukui 910-1193, Japan

Received 11 February 2014; Accepted 26 March 2014; Published 13 April 2014

Academic Editor: Enrico Heffler

Copyright © 2014 Hisako Hayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Herzog and R. Bucala, “Fibrocytes in health and disease,” Experimental Hematology, vol. 38, no. 7, pp. 548–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Reilkoff, R. Bucala, and E. L. Herzog, “Fibrocytes: emerging effector cells in chronic inflammation,” Nature Reviews Immunology, vol. 11, no. 6, pp. 427–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Peng and E. L. Herzog, “Fibrocytes: emerging effector cells in chronic inflammation,” Current Opinion in Pharmacology, vol. 12, no. 4, pp. 491–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Abe, S. C. Donnelly, T. Peng, R. Bucala, and C. N. Metz, “Peripheral blood fibrocytes: differentiation pathway and migration to wound sites,” Journal of Immunology, vol. 166, no. 12, pp. 7556–7562, 2001. View at Google Scholar · View at Scopus
  5. M. W. Epperly, H. Guo, J. E. Gretton, and J. S. Greenberger, “Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 2, pp. 213–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. Phillips, M. D. Burdick, K. Hong et al., “Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis,” Journal of Clinical Investigation, vol. 114, no. 3, pp. 438–446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Schmidt, G. Sun, M. A. Stacey, L. Mori, and S. Mattoli, “Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma,” Journal of Immunology, vol. 171, no. 1, pp. 380–389, 2003. View at Google Scholar · View at Scopus
  8. B. Mehrad, M. D. Burdick, D. A. Zisman, M. P. Keane, J. A. Belperio, and R. M. Strieter, “Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease,” Biochemical and Biophysical Research Communications, vol. 353, no. 1, pp. 104–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Nihlberg, K. Larsen, A. Hultgårdh-Nilsson, A. Malmström, L. Bjermer, and G. Westergren-Thorsson, “Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?” Respiratory Research, vol. 7, p. 50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Wang, C. D. Huang, H. C. Lin et al., “Increased circulating fibrocytes in asthma with chronic airflow obstruction,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 6, pp. 583–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Bellini, M. A. Marini, L. Bianchetti, M. Barczyk, M. Schmidt, and S. Mattoli, “Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients,” Mucosal Immunology, vol. 5, no. 2, pp. 140–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. B. N. Lambrecht and H. Hammad, “Asthma: the importance of dysregulated barrier immunity,” European Journal of Immunology, vol. 43, no. 12, pp. 3125–3137, 2013. View at Publisher · View at Google Scholar
  13. C. H. Wang, C. D. Huang, H. C. Lin et al., “Increased activation of fibrocytes in patients with chronic obstructive asthma through an epidermal growth factor receptor-dependent pathway,” Journal of Allergy and Clinical Immunology, vol. 129, no. 5, pp. 1367–1376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ohno, H. Morita, K. Arae et al., “Interleukin-33 in allergy,” Allergy, vol. 67, no. 10, pp. 1203–1214, 2012. View at Google Scholar
  15. A. S. Mirchandani, R. J. Salmond, and F. Y. Liew, “Interleukin-33 and the function of innate lymphoid cells,” Trends in Immunology, vol. 33, no. 8, pp. 389–396, 2012. View at Google Scholar
  16. R. J. Salmond, A. S. Mirchandani, A. G. Besnard et al., “IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin,” The Journal of Allergy and Clinical Immunology, vol. 130, no. 5, pp. 1159–1166, 2012. View at Google Scholar
  17. D. Préfontaine, J. Nadigel, F. Chouiali et al., “Increased IL-33 expression by epithelial cells in bronchial asthma,” Journal of Allergy and Clinical Immunology, vol. 125, no. 3, pp. 752–754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Allakhverdi, M. R. Comeau, D. E. Smith et al., “CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 472–478, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Hams and P. G. Fallon, “Innate type 2 cells and asthma,” Current Opinion in Pharmacology, vol. 12, no. 4, pp. 503–509, 2012. View at Google Scholar
  20. J. A. Walker and A. McKenzie, “Innate lymphoid cells in the airways,” European Journal of Immunology, vol. 42, no. 6, pp. 1368–1374, 2012. View at Google Scholar
  21. H. Hayashi, A. Kawakita, S. Okazaki et al., “IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling,” Inflammation, vol. 36, no. 4, pp. 830–838, 2013. View at Google Scholar
  22. L. Bianchetti, M. A. Marini, M. Isgro et al., “IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma,” Biochemical and Biophysical Research Communications, vol. 426, no. 1, pp. 116–121, 2012. View at Google Scholar
  23. C. García-de-Alba, C. Becerril, V. Ruiz et al., “Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 9, pp. 1144–1152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Hartlapp, A. B. E. Riichiro, R. W. Saeed et al., “Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo,” FASEB Journal, vol. 15, no. 12, pp. 2215–2224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. T. S. Hallstrand and W. R. Henderson Jr., “An update on the role of leukotrienes in asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 10, no. 1, pp. 60–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Bucala, “Review series—inflammation & fibrosis. Fibrocytes and fibrosis,” QJM, vol. 105, no. 6, pp. 505–508, 2012. View at Google Scholar
  27. K. M. Vannella, T. R. McMillan, R. P. Charbeneau et al., “Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function,” Journal of Immunology, vol. 179, no. 11, pp. 7883–7890, 2007. View at Google Scholar · View at Scopus
  28. R. Saunders, S. Siddiqui, D. Kaur et al., “Fibrocyte localization to the airway smooth muscle is a feature of asthma,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 376–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Ingram and M. Kraft, “IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies,” The Journal of Allergy and Clinical Immunology, vol. 130, no. 4, pp. 829–842, 2012. View at Google Scholar
  30. A. Semlali, E. Jacques, L. Koussih, A. S. Gounni, and J. Chakir, “Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway,” Journal of Allergy and Clinical Immunology, vol. 125, no. 4, pp. 844–850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kato, S. Favoreto Jr., P. C. Avila, and R. P. Schleimer, “TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells,” Journal of Immunology, vol. 179, no. 2, pp. 1080–1087, 2007. View at Google Scholar · View at Scopus
  32. Q. Yu and I. Stamenkovic, “Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis,” Genes and Development, vol. 14, no. 2, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  33. L. A. Murray, Q. Chen, M. S. Kramer et al., “TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 1, pp. 154–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Sakai, K. Furuichi, Y. Shinozaki et al., “Fibrocytes are involved in the pathogenesis of human chronic kidney disease,” Human Pathology, vol. 41, no. 5, pp. 672–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Préfontaine, S. Lajoie-Kadoch, S. Foley et al., “Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells,” Journal of Immunology, vol. 183, no. 8, pp. 5094–5103, 2009. View at Publisher · View at Google Scholar · View at Scopus